Table 5 Cardiac medications
MI, N (%) (N = 37) | Elevated cTn, N (%) (N = 15) | No cTn elevation, N (%) (N = 51) | p value1 | p value2 | |
|---|---|---|---|---|---|
Antiplatelet agents | 26 (70.3) | 7 (46.7) | 16 (31.4) | 0.001 | - MI vs cTn, p = 0.126 - cTn vs no cTn elevation, p = 0.358 - MI vs no cTn elevation, p < 0.0001 |
Anticoagulant UFH | 7 (19.4) | 0 (0) | 0 (0) | 0.001 | - MI vs cTn, p = 0.090 - cTn vs no cTn elevation, p = NE - MI vs no cTn elevation, p = 0.001 |
Anticoagulant LMWH | 3 (8.3) | 0 (0) | 0 (0) | 0.064 | - MI vs cTn, p = 0.546 - cTn vs no cTn elevation, p = NE - MI vs no cTn elevation, p = 0.072 |
Anticoagulant Warfarin | 8 (22.2) | 3 (20.0) | 4 (8.0) | 0.156 | - MI vs cTn, p = 1.000 - cTn vs no cTn elevation, p = 0.338 - MI vs no cTn elevation, p = 0.112 |
Long acting nitrates | 19 (51.4) | 5 (33.3) | 6 (12.0) | <0.0001 | - MI vs cTn, p = 0.358 - cTn vs no cTn elevation, p = 0.109 - MI vs no cTn elevation, p < 0.0001 |
Statin | 19 (51.4) | 7 (46.7) | 18 (35.3) | 0.306 | - MI vs cTn, p = 1.000 - cTn vs no cTn elevation, p = 0.547 - MI vs no cTn elevation, p = 0.189 |
ACE inhibitors/ARBs | 11 (29.7) | 5 (33.3) | 7 (14.0) | 0.123 | - MI vs cTn, p = 1.000 - cTn vs no cTn elevation, p = 0.128 - MI vs no cTn elevation, p = 0.108 |
Beta-blockers | 25 (67.6) | 5 (33.3) | 20 (39.2) | 0.014 | - MI vs cTn, p = 0.032 - cTn vs no cTn elevation, p = 0.769 - MI vs no cTn elevation, p = 0.010 |
Calcium channel blocker | 13 (35.1) | 4 (26.7) | 11 (21.6) | 0.369 | - MI vs cTn, p = 0.747 - cTn vs no cTn elevation, p = 0.731 - MI vs no cTn elevation, p = 0.225 |
Diuretic | 25 (67.6) | 9 (60.0) | 17 (33.3) | 0.004 | - MI vs cTn, p = 0.749 - cTn vs no cTn elevation, p = 0.078 - MI vs no cTn elevation, p = 0.002 |
Digoxin | 8 (22.2) | 0 (0) | 2 (3.9) | 0.007 | - MI vs cTn, p = 0.087 - cTn vs no cTn elevation, p = 0.594 - MI vs no cTn elevation, p = 0.014 |